The current status of CAR T and CAR NK cells in multiple myeloma

The current status of CAR T and CAR NK cells in multiple myeloma

CAR-T Cell Therapy: Current Uses and Future PossibilitiesПодробнее

CAR-T Cell Therapy: Current Uses and Future Possibilities

Kenneth C. Anderson - Multiple myeloma cured in 2030: what are the next steps?Подробнее

Kenneth C. Anderson - Multiple myeloma cured in 2030: what are the next steps?

Update in Multiple MyelomaПодробнее

Update in Multiple Myeloma

What are dual CAR-T cells? #myelomaПодробнее

What are dual CAR-T cells? #myeloma

Bispecific Monoclonal Antibodies and CAR T-Cell Therapy in Multiple Myeloma, Omar Nadeem, MDПодробнее

Bispecific Monoclonal Antibodies and CAR T-Cell Therapy in Multiple Myeloma, Omar Nadeem, MD

CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized MedicineПодробнее

CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine

Addressing CAR-NK unknownsПодробнее

Addressing CAR-NK unknowns

CAR-T vs CAR-NK for myelomaПодробнее

CAR-T vs CAR-NK for myeloma

AlloCARs and CAR-NK cells in myelomaПодробнее

AlloCARs and CAR-NK cells in myeloma

Role of CAR T Therapy in Treatment Strategies - Ravi Vij, MD | MCRT Webcast October 31 (8/10)Подробнее

Role of CAR T Therapy in Treatment Strategies - Ravi Vij, MD | MCRT Webcast October 31 (8/10)

Exploring Challenges With CAR T Cells and NK Cells in Multiple MyelomaПодробнее

Exploring Challenges With CAR T Cells and NK Cells in Multiple Myeloma

Monoclonal Antibodies and CAR T-cell Therapy in Myeloma: Current Status by Yi Lin, MD, PhD | PreviewПодробнее

Monoclonal Antibodies and CAR T-cell Therapy in Myeloma: Current Status by Yi Lin, MD, PhD | Preview

NKG2D-CAR Transduced Primary Natural Killer Cells Efficiently Target Multiple Myeloma CellsПодробнее

NKG2D-CAR Transduced Primary Natural Killer Cells Efficiently Target Multiple Myeloma Cells

Новости